Fil LTD Gilead Sciences, Inc. Transaction History

Fil LTD

$103 Billion
Q3 2024

A detailed history of Fil LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fil LTD holds 40,853 shares of GILD stock, worth $3.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,853

Previous 39,032 4.67%

Holding current value

$3.78 Million

Previous $2.68 Million 27.9%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $121,260 - $152,945	1,821 Added 4.67%	40,853 $3.42 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $2.2 Million - $2.54 Million	34,814 Added 825.37%	39,032 $2.68 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $301,924 - $368,189	4,218 New	4,218 $308,000
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $3.55 Million - $4.05 Million	-46,735 Reduced 35.03%	86,676 $6.68 Million
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $3.2 Million - $3.64 Million	-41,340 Reduced 23.66%	133,411 $11.1 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $1.13 Million - $1.63 Million	18,185 Added 11.61%	174,751 $15 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $3.94 Million - $4.5 Million	66,224 Added 73.3%	156,566 $9.66 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $1.1 Million - $1.24 Million	19,120 Added 26.85%	90,342 $5.58 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $17.9 Million - $22.5 Million	-309,734 Reduced 81.3%	71,222 $4.23 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $8.9 Million - $10.1 Million	-137,158 Reduced 26.47%	380,956 $27.7 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $2.88 Million - $3.11 Million	-42,533 Reduced 7.59%	518,114 $36.2 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $1.01 Million - $1.1 Million	15,837 Added 2.91%	560,647 $38.6 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $32.7 Million - $37.3 Million	544,522 Added 189070.14%	544,810 $35.2 Million
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $21,923 - $24,980	-387 Reduced 57.33%	288 $17,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $24.5 Million - $30.8 Million	-394,661 Reduced 99.83%	675 $43,000
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $28.5 Million - $33.1 Million	394,575 Added 51849.54%	395,336 $30.4 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $15.6 Million - $20 Million	-249,621 Reduced 99.7%	761 $57,000
Q4 2019 Feb 07, 2020	SELL	$61.62 - $67.78 $7.39 Million - $8.13 Million	-119,999 Reduced 32.4%	250,382 $16.3 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $109 Million - $120 Million	-1,736,191 Reduced 82.42%	370,381 $23.5 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $16.1 Million - $18 Million	259,465 Added 14.05%	2,106,572 $142 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $72.3 Million - $81 Million	-1,156,062 Reduced 38.49%	1,847,107 $120 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $9.95 Million - $13 Million	-164,356 Reduced 5.19%	3,003,169 $188 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $23.6 Million - $26.1 Million	331,219 Added 11.68%	3,167,525 $245 Million
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $42.8 Million - $49.9 Million	659,695 Added 30.31%	2,836,306 $201 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $6.13 Million - $7.47 Million	84,170 Added 4.02%	2,176,611 $164 Million
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $2.91 Million - $3.42 Million	40,924 Added 1.99%	2,092,441 $150 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $41.6 Million - $49.4 Million	577,397 Added 39.17%	2,051,517 $166 Million
Q2 2017 Aug 29, 2017	BUY	N/A	1,474,120	1,474,120 $104 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account